Zydus Lifesciences has received approval from the US FDA to market Lacosamide Tablets, a generic anti-epileptic medication used to treat partial-onset seizures and primary generalized tonic-clonic seizures. The product will be manufactured at the company's manufacturing facility in Ahmedabad.
